SARS‐CoV‐2 and adverse reactions to SARS‐CoV‐2 vaccinations show a tropism for
neuronal structures and tissues. This narrative review was conducted to collect and discuss …

Following the COVID-19 virus epidemic, extensive, coordinated international research has
led to the rapid development of effective vaccines. Although vaccines are now considered …

Vaccines based on mRNA-containing lipid nanoparticles (LNPs) are a promising new
platform used by two leading vaccines against COVID-19. Clinical trials and ongoing …

Abstract The mRNA SARS-CoV-2 vaccines were brought to market in response to the public
health crises of Covid-19. The utilization of mRNA vaccines in the context of infectious …

Background Since the emergency use approval of different types of COVID-19 vaccines,
several safety concerns have been raised regarding its early and delayed impact on the …

Vaccine‐associated multiple sclerosis (MS) is rare, with insufficient evidence from case
reports. Given the scarcity of large‐scale data investigating the association between vaccine …

COVID-19 vaccines were developed and approved rapidly in response to the urgency
created by the pandemic. No specific regulations existed at the time they were marketed …

COVID-19 remains a deadly disease that poses a serious threat to humanity. COVID-19
vaccines protect the public and limit viral spread. However, public acceptance is significantly …

The novel mRNA vaccinations against COVID-19 are gaining worldwide attention for their
potential efficacy, as well as for the diagnosis of some post-vaccination-reported adverse …

Evidence has suggested an increased risk of psychiatric manifestations following viral
infections including coronavirus disease-2019 (COVID-19). However, psychiatric adverse …